Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Pulmonary arterial hypertension (PAH) is a rare dyspnoea-fatigue syndrome caused by a
progressive increase in pulmonary vascular resistance and eventual right ventricular (RV) …

Research in the last decade has substantially advanced our understanding of the
pathophysiology of heart failure with preserved ejection fraction (HFpEF). However …

In patients with left ventricular heart failure (HF), the development of pulmonary hypertension
(PH) and right ventricular (RV) dysfunction are frequent and have important impact on …

Right ventricular (RV) failure remains a major cause of global morbidity and mortality for
patients with advanced heart failure, pulmonary hypertension, or acute myocardial infarction …

Pulmonary hypertension is a pathological haemodynamic condition defined as an increase
in mean pulmonary arterial pressure≥ 25 mmHg at rest, assessed using gold standard …

Pulmonary hypertension is defined as a mean arterial pressure of≥ 25 mmHg as confirmed
on right heart catheterisation. Traditionally, the pulmonary arterial systolic pressure has …

Pulmonary arterial hypertension is most often diagnosed in its advanced stages because of
the nonspecific nature of early symptoms and signs. Although clinical assessment is …

Pulmonary hypertension associated with left heart disease is the most common form of
pulmonary hypertension encountered in clinical practice today. Although frequently a target …

Background Pulmonary artery acceleration time (PAAT) is a noninvasive method to assess
pulmonary hemodynamics, but it lacks validity in children. The aim of this study was to …